FDA Inspection 1135959 — Kristen NooShin Ganjoo, M.D.
The FDA completed an inspection of Kristen NooShin Ganjoo, M.D. on February 8, 2021 in Palo Alto, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 8, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Palo Alto, CA (United States)
Additional Details
Clinical Investigator (CI)